Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × tanespimycin × Clear all

NCT01193491 2015-04-15

Dose Escalation of IPI-493 in Hematologic Malignancies

Phase 1 Terminated

Other hematologic neoplasm

Hematologic Neoplasms

NCT00113204 2008-05-20

IPi-504-01

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Hematologic Diseases, Multiple Myeloma, Recurrence, Hematologic Neoplasms